STT3 oligosaccharyltransferase complex catalytic subunit A
RGD ID:
1565793
Description:
Predicted to enable dolichyl-diphosphooligosaccharide-protein glycotransferase activity. Predicted to be involved in co-translational protein modification and protein N-linked glycosylation via asparagine. Predicted to be located in membrane. Predicted to be part of oligosaccharyltransferase III complex. Human ortholog(s) of this gene implicated in congenital disorder of glycosylation Iw. Orthologous to human STT3A (STT3 oligosaccharyltransferase complex catalytic subunit A); PARTICIPATES IN Endoplasmic Reticulum-associated degradation pathway; N-linked glycan biosynthetic pathway; INTERACTS WITH 17beta-estradiol; acrylamide; bisphenol A.
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A; integral membrane protein 1; integral transmembrane protein 1; integral transmembrane protein 1 (mapped); Itm1; Itm1_mapped; LOC500972; MGC188229; RGD1565793; similar to integral membrane protein 1; STT3, subunit of the oligosaccharyltransferase complex, homolog A; STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae); STT3A, catalytic subunit of the oligosaccharyltransferase complex; STT3A, subunit of the oligosaccharyltransferase complex (catalytic)
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STT3A mRNA
[ginger extract results in increased abundance of Oils and Volatile] inhibits the reaction [bisphenol A results in increased expression of STT3A protein]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STT3A mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STT3A mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STT3A mRNA